EUROLEPTICS TARGETING METABOTROPIC GLUTAMATE RECEPTOR (GRM5): MOLECULAR DOCKING STUDIES OF SUBSTITUTED QUINOLINES

Authors

  • PORAPU RAJA, TUMMALAPALLI MOUNIKA, DONTIREDDY RAVI SANKARA REDDY Author

DOI:

https://doi.org/10.48047/

Keywords:

GRM5 receptor, Schizophrenia, Quinoline derivatives, Molecular Docking, iGEMDOCK Software, Discovery Studio Visualizer.

Abstract

Schizophrenia, a complex neuropsychiatric disorder having significant health challenges like 
physical, psychological and social issues globally. To reduce those by the management of 
schizophrenia with novel quinoline derivatives, as it poses various pharmacological properties 
including potential antipsychotic activity

Downloads

Download data is not yet available.

Downloads

Published

2025-05-15

Issue

Vol. 16 No. 5 (2025): Volume 16 Issue 5 (2025)

Section

Articles